Both MORT and REET are real estate exchange-traded funds, yet they target distinct segments of the sector. MORT focuses on mortgage real estate investment trusts that lend against or hold mortgage-backed securities instead of physical assets. REET, on the other hand, provides exposure to equity REITs that own and manage income-generating properties such as warehouses, data centers, healthcare facilities, and retail spaces. This comparison feels especially relevant now, as investors evaluate income generation versus diversification amid ongoing rate sensitivity.
The VanEck Mortgage REIT Income ETF (MORT) tracks the MVIS US Mortgage REITs Index in a rules-based, passive manner. It allocates at least 80% of assets to the largest and most liquid U.S. mortgage REITs, which focus on purchasing or servicing commercial and residential mortgage loans and related securities. The fund typically holds around 27 positions and is considered non-diversified. Its top holdings include NLY, AGNC, STWD, RITM, and DX, with the top 10 names making up roughly 70% of assets. The expense ratio sits near 0.42%, and distributions occur quarterly. Leverage within the underlying mREITs supports higher yields but also heightens sensitivity to rate changes and credit conditions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The iShares Global REIT ETF (REET) follows the FTSE EPRA Nareit Global REITs Index, covering equity REITs that own and operate income-producing real estate in both developed and emerging markets. It holds approximately 351 securities, with the largest country weights in the United States, followed by Australia, Japan, and the United Kingdom. Leading positions include WELL, PLD, EQIX, SPG, and DLR, accounting for just over 40% of assets combined. Allocations span retail, healthcare, industrial, data center, and residential sectors. The fund maintains a low 0.14% expense ratio with quarterly distributions, delivering market-cap-weighted exposure that reduces concentration risk relative to MORT.
Interest-rate dynamics heavily influence the comparison. Mortgage REITs generate returns from the spread between short-term borrowing costs and mortgage asset yields, leaving MORT particularly exposed to policy shifts, yield-curve movements, and credit spreads. Equity REITs, by contrast, respond more to property-level factors such as occupancy rates, rent growth, and capital flows into sectors like data centers and logistics. Recent cycles have benefited technology-related real estate, supporting REET. While regulatory and financing conditions affect both, MORT's leveraged structure brings elevated yield alongside greater risk, whereas REET emphasizes broader economic diversification and lower volatility.
Recent periods have highlighted MORT's high-yield yet volatile profile, with notable drawdowns when rate expectations rose. REET has delivered more measured gains, backed by steady demand in industrial, data center, and healthcare properties. The funds serve different roles: MORT functions as a niche, income-focused instrument, while REET serves as a core diversified holding. REET generally shows lower beta, reduced expenses, and wider diversification, although MORT's larger distribution yield compensates for its higher risk profile.
Based on the factors reviewed, Tickeron's AI would likely favor REET over MORT in the current setting. REET benefits from its lower expense ratio, broader diversification across roughly 351 holdings, reduced volatility and beta, and steadier momentum in areas such as data centers and healthcare. MORT's double-digit yield remains appealing, yet it carries notably higher interest-rate and leverage risks that can lead to larger drawdowns. Investors seeking structural resilience, cost efficiency, and risk-adjusted positioning may find REET more compelling, while those prioritizing income might still consider MORT's yield alongside its elevated risk.
When comparing ETFs such as these, I often turn to Tickeron’s AI Screener to apply filters on technical patterns, fundamentals, and performance metrics. This helps surface relative strengths and build more informed watchlists without manual effort across thousands of securities.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Oscillator for MORT moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on MORT as a result. In 73 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for MORT just turned positive on October 15, 2026. Looking at past instances where MORT's MACD turned positive, the stock continued to rise in 36 of 43 cases over the following month. The odds of a continued upward trend are 84%.
Following a +2.77% 3-day Advance, the price is estimated to grow further. Considering data from situations where MORT advanced for three days, in 242 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
MORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 56 of 71 cases where MORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for MORT entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category RealEstate